← RESOURCES
[ FDA · GUIDANCE DOCUMENTS ]
What the FDA is telling industry to do next.
FDA guidance documents set the Agency’s current thinking — and draft guidance signals where expectations are heading before they are final. Much of it never appears in the Federal Register. SPEQ tracks the newest draft and final guidances with their issue date, status, and a link to each.
14
Guidances tracked
Jul 27, 2026
Most recent
3 draft · 11 final
Status split
Jul 27, 2026FINAL
Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications: Guidance for Industry, IRBs, and Clinical Investigators
View details →
Jul 27, 2026FINAL
Cancer Clinical Trial Eligibility Criteria: Performance Status: Guidance for Industry, IRBs, and Clinical Investigators
View details →
Jul 27, 2026FINAL
Cancer Clinical Trial Eligibility Criteria: Laboratory Values: Guidance for Industry, IRBs, and Clinical Investigators
View details →
Jul 23, 2026FINAL
Hemodialysis Blood Tubing Sets - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff
View details →
Jul 14, 2026FINAL
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
View details →
Jul 14, 2026FINAL
Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs
View details →
Jul 14, 2026FINAL
Psychedelic Drugs: Considerations for Clinical Investigations
View details →
Jul 1, 2026FINAL
Submitting Next-Generation Sequencing Data to the Division of Antiviral Products
View details →
Jun 29, 2026FINAL
Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus: Guidance for Industry
View details →
Jun 24, 2026DRAFT
Master Protocols for Drug and Biological Product Development
View details →
Jun 24, 2026DRAFT
Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials
View details →
Jun 24, 2026DRAFT
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products: Draft Guidance for Industry
View details →
Jun 23, 2026FINAL
CVM GFI #110 (VICH GL16) Effectiveness of Anthelmintics: Specific Recommendations for Porcines
View details →
Jun 23, 2026FINAL
CVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines
View details →
Source: FDA guidance database (fda.gov), scraped and refreshed daily. Only rows verified against the live page are stored (a markdown-verification guard). Guidances are FDA records reproduced as published — SPEQ adds no interpretation. The archive builds forward from the first scan.